Showing 161-170 of 1560 results for "".
Diagnosing and Staging Non-Small Cell Lung Cancer: Key Updates and Evolving Strategies
https://reachmd.com/programs/deep-breaths-updates-chest/diagnosing-and-staging-non-small-cell-lung-cancer-key-updates-and-evolving-strategies/35979/For patients with non-small cell lung cancer, staging accuracy is critical in guiding treatment decisions that can significantly affect outcomes. In this expert-led discussion, Dr. Gerard Silvestri sits down with Drs. Anne Gonzalez and Jeffrey Velotta break down what clinicians need to know, includiTargeting CCR4 in CAR-Associated Peripheral T-Cell Lymphoma
https://reachmd.com/programs/project-oncology/targeting-ccr4-in-car-associated-peripheral-t-cell-lymphoma/37205/Targeting the Fc Receptor Pathway to Treat Red Blood Cell Alloimmunization
https://reachmd.com/programs/cme/targeting-the-fc-receptor-pathway-to-treat-red-blood-cell-alloimmunization/13908/Delve deeper into the basic biology and functions of the FcRn receptor. Could it be the key to solving the clinical conundrum of HDFN?Reducing the Burden of gMG with a Novel B-Cell Therapy
https://reachmd.com/programs/neurofrontiers/reducing-the-burden-of-gmg-with-a-novel-b-cell-therapy/35496/Despite therapeutic advances, many generalized myasthenia gravis (gMG) patients continue to struggle with inadequately controlled disease, underscoring the importance of broadening treatment options that reduce disease burden while offering durable symptom control. With its novel mechanism of actionCrohn’s & Colitis Congress: Environmental Triggers & Stemming the Rising Tide of IBD
https://reachmd.com/programs/crohns-colitis-foundation-perspectives/crohns-colitis-congress-environmental-triggers-and-stemming-the-rising-tide-of-ibd/10749/Could helping your patients manage their IBD inflammation be as easy as adjusting their diet and regaining control of environmental triggers?Consensus and Standards to Improve Continuity of Care in Sickle Cell Disease
https://reachmd.com/programs/clinicians-roundtable/consensus-and-standards-to-imrpove-continuity-of-care-in-sickle-cell-disease/24061/Red Blood Cell Alloimmunization, Pathophysiology, Diagnosis, Treatment, and Prevention
https://reachmd.com/programs/cme/red-blood-cell-alloimmunization-pathophysiology-diagnosis-treatment-and-prevention/13907/HDFN is rare, under recognized, and undermanaged. Are you doing everything you can to mitigate potentially devastating outcomes for your patients?Impact of DLL3-Directed Immunotherapy on the Small Cell Lung Cancer Landscape
https://reachmd.com/programs/project-oncology/impact-of-dll3-directed-immunotherapy-on-the-small-cell-lung-cancer-landscape/36454/Immune Cells: Are They the Key to Better Allergy and Infection Therapies?
https://reachmd.com/programs/primary-care-today/immune-cells-are-they-key-better-allergy-and-infection-therapies/9824/Dr. Avery August talks about the molecular and fundamental mechanisms behind allergic reactions and autoimmunity.Reimagining Lung Cancer Treatment: A Journey Through New and Emerging Therapeutics Related to the Care of Patients with Small Cell and Non-Small Cell Lung Cancer
https://reachmd.com/programs/cme/reimagining-lung-cancer-treatment-a-journey-through-new-and-emerging-therapeutics-related-to-the-care-of-patients-with-small-cell-and-non-small-cell-lung-cancer/35653/Reimagine lung cancer care—discover how new and emerging therapies are reshaping the treatment of SCLC and NSCLC